Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rein Therapeutics (RNTX) Change in Acquisitions & Divestments (2016 - 2023)

Rein Therapeutics filings provide 8 years of Change in Acquisitions & Divestments readings, the most recent being $500000.0 for Q3 2023.

  • For the quarter ending Q3 2023, Change in Acquisitions & Divestments fell 95.83% year-over-year to $500000.0, compared with a TTM value of $500000.0 through Jun 2024, down 98.55%, and an annual FY2023 reading of $16.2 million, down 66.36% over the prior year.
  • Change in Acquisitions & Divestments hit $500000.0 in Q3 2023 for Rein Therapeutics, down from $8.5 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $23.8 million in Q3 2021, with the low at $500000.0 in Q3 2023.
  • Median Change in Acquisitions & Divestments over the past 5 years was $7.0 million (2019), compared with a mean of $7.5 million.
  • The sharpest move saw Change in Acquisitions & Divestments soared 1257.2% in 2021, then tumbled 95.83% in 2023.
  • Year by year, Change in Acquisitions & Divestments stood at $7.5 million in 2019, then tumbled by 80.02% to $1.5 million in 2020, then soared by 233.33% to $5.0 million in 2021, then skyrocketed by 34.04% to $6.7 million in 2022, then tumbled by 92.54% to $500000.0 in 2023.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $500000.0, $8.5 million, and $7.2 million for Q3 2023, Q2 2023, and Q1 2023 respectively.